Table II.
Costs of arterial hypertension
| Record | Total costs (TC)/Total costs per person (TCpp) Direct costs (DC)/Direct costs per person (DCpp) Indirect costs (IC)/Indirect costs per person (ICpp) | Hospital costs (HC)/ Hospital costs per person (HCpp) Hospital costs per admission (HCpa) Drug costs (DrC)/Drug costs per person (DrCpp) | Pharmaceutical care costs (PCC)/Pharmaceutical care costs per person (PCCpp) Out-of-pocket expenses (OOPE) Costs of stroke (COS)/Costs of stroke per person (COSpp) |
|---|---|---|---|
| Alvarez-Sabin 2016 [15] | 41,575.54 Int$ (COSpp) | ||
| Arredondo 2015 [16] | 6,880,020,349.00 Int$ (TC) 3,261,937,129.00 Int$ (DC) 3,618,083,220.00 Int$ (IC) |
358,812,888.00 Int$ (HC) 456,671,390.00 Int$ (DrC) |
411,003,513.00 Int$ (COS) |
| Arredondo 2016 [17] | 8,297,635.00 Int$ (DC – Hidalgo)/796.17 Int$ (DCpp – Hidalgo) 18,413,820.00 Int$ (DC – Jalisco)/590.77 Int$ (DCpp – Jalisco) 10,007,786.00 Int$ (DC – Morelos)/625.10 Int$ (DCpp – Morelos) 14,769,269.00 Int$ (DC – Sinaloa)/470.27 Int$ (DCpp – Sinaloa) 5,485,622.00 Int$ (DC – Yucatán)/579.57 Int$ (DCpp – Yucatán) |
||
| Bernard 2014 [18] | 174.00 Int$ (OOPE) | ||
| Bigdeli 2016 [19] | 399.00 Int$ (DCpp) | 350.00 Int$ (DrCpp) | |
| Boan 2014 [20] | 2,770,000,000.00 Int$ (COS) | ||
| Boubouchairopoulou 2014 [21] | 2,411.62 Int$ (DCpp) | 405.24 Int$ (DrCpp) | |
| Bueno 2017 [22] | 30.23 Int$ (DrCpp) | ||
| Cazarim 2018 [23] | 23,350.38 Int$ (PCC)/224.52 Int$ (PCCpp) | ||
| Finkelstein 2014 [24] | 1,320,000,000.00 Int$ (TC)/70.00 Int$ (TCpp) 540,000,000.00 Int$ (DC)/30.00 Int$ (DCpp) 780,000,000.00 Int$ (IC)/50.00 Int$ (ICpp) |
290,000,000.00 Int$ (COS)/380.00 Int$ (COSpp) |
|
| Gilmer 2014 [25] | 1,972.00 Int$ (DCpp) | ||
| Huang 2016 [26] | 193.32 Int$ (DCpp) | 2,967.90 Int$ (HCpa) | 45.68 Int$ (OOPE) |
| Kawalec 2015 [27] | 9,439.26 Int$ (OOPE) | ||
| Kirkland 2018 [28] | 9,089.00 Int$ (DCpp) | 2,731.00 Int$ (HCpp) 2,371.00 Int$ (DrCpp) |
|
| Lekoubou 2018 [29] | 316,000,000,000.00 Int$ (TC) 193,000,000,000.00 Int$ (DC) 123,000,000,000.00 Int$ (IC) |
98,300,000,000.00 Int$ (COS)/17,165.00 Int$ (COSpp) |
|
| Liu 2016 [30] | 1,936.23 Int$ (HCpa) | ||
| Marra 2017 [31] | 209,658.38 Int$ (PCC) 64,093.83 Int$ (COSpp) |
||
| Milan 2017 [32] | 28.78 Int$ (OOPE) | ||
| Mitchell-Fearon 2017 [10] | 204,676,723.54 Int$ (TC)/1,190.28 Int$ (TCpp) 116,173,000.90 Int$ (DC)/675.59 Int$ (DCpp) 88,503,722.64 Int$ (IC)/514.68 Int$ (ICpp) |
10,851,082.11 Int$ (HC)/3.10 Int$ (HCpp) 37,038,595.58 Int$ (DrC)/215.39 Int$ (DrCpp) |
3,000.00 Int$ (OOPE) |
| Moise 2016 [33] | 11,994.00 Int$ (HCpp) | 26,000.00 Int$ (COSpp) | |
| Murphy 2016 [34] | 12.70 Int$ (OOPE) | ||
| Mutowo 2016 [35] | 914.00 Int$ (HCpa) | ||
| Nguyen 2014 [36] | 64.95 Int$ (HCpa) | ||
| Paczkowska 2014 [37] | 116.08 Int$ (DCpp) | 159.82 Int$ (HCpp) 68.84 Int$ (DrCpp) |
|
| Park 2017 [38] | 9,841.00 Int$ (DCpp) | 9,555.00 Int$ (COSpp) | |
| Ricci 2017 [39] | 3,666,930,171.28 Int$ (DC) | ||
| Ritchey 2016 [40] | 28,810,000,000.00 Int$ (DrC) | 359.00 Int$ (OOPE) | |
| Shireman 2016 [41] | 104.80 Int$ (PCCpp) | ||
| Specogna 2017 [42] | 12,856.72 Int$ (COSpp) | ||
| Stafylas 2015 [43] | 4,154.65 Int$ (HCpp) 10,877.88 Int$ (DrCpp) |
||
| Tajeu 2017 [44] | 189.48 Int$ (DrCpp) | 69,642.00 Int$ (COSpp) | |
| Tamblyn 2018 [45] | 436.77 Int$ (DrCpp) | 209.03 Int$ (OOPE) | |
| Vasudeva 2016 [46] | 12,000.00 Int$ (HCpp) | 26,000.00 Int$ (COSpp) | |
| Wang G. 2017 [47] | 8,854.00 Int$ (DCpp) | ||
| Wang G., Fang J. 2014 [48] | 113,390,000,000.00 Int$ (HC) 8,480.00 Int$ (HCpa) |
||
| Wang G., Zhang Z. 2014 [49] | 23,256.00 Int$ (COSpp) | ||
| Wang Q. 2014 [50] | 93.50 Int$ (OOPE) | ||
| Wang Z. 2017 [51] | 63.40 Int$ (DrCpp) | ||
| Weaver 2015 [52] | 11,300,813,008.13 Int$ (DC)/1,903.25 Int$ (DCpp) |
||
| Zhang 2017 [53] | 1494.00 USD Int$ (DCpp) |